Search clinical trials for: Mild to Moderate Asthma

Total 476845 results

Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

A First-in-human, Single-ascending-dose Study of IBI3002 in Healthy Participants and Mild to Moderate Asthmatics

Asthma | Healthy Participants

Australia
Bausch Health Americas, Inc.

Not yet recruiting

Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Rectal Foam in Pediatric Patients Aged 5 to 17 Years With Active, Mild to Moderate Distal Ulcerative Colitis

Ulcerative Colitis
Amgen

Recruiting

A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-ASCEND)

Atopic Dermatitis

United States, Japan, Korea, Republic of, Australia, Taiwan, Spain, Switzerland, Germany, Croatia, Austria, Bulgaria, France, Denmark, China, Netherlands, Hungary, Czechia, Poland, Brazil, Greece, Portugal, Italy, Finland, Argentina, Sl... and more
Wolfson Medical Center

Recruiting

Combination of Diet and Oral Budesonide for Ulcerative Colitis (ReDUCE)

Ulcerative Colitis | Ulcerative Colitis Chronic Moderate | Ulcerative Colitis Chronic Mild

Switzerland, Israel, Italy, Netherlands
Ain Shams University

Not yet recruiting

A Study of Step-up in Bronchial Asthma as a New End Point (SURFE) (SURFE)

Bronchial Asthma
Inmunotek S.L.
BioClever 2005 S.L.; NTS hub S.L

Not yet recruiting

Efficacy and Safety Evaluation for the Treatment of HDM Induced Allergic Asthma and Rhinitis/Rhinoconjunctivitis

Perennial Allergic Rhinitis | Allergic Asthma | Allergic Rhinoconjunctivitis | House Dust Mite Allergy

Spain
Puressentiel

Not yet recruiting

Effects of Puressentiel Purifying Spray on Asthma Control in Patients With Mild to Moderate Allergy-induced Asthma. (PSIndAC)

Asthma, Allergic
Assiut University

Not yet recruiting

Budesonide Multimatrix(MMX) Versus Prednisolone in Management of Mild to Moderate Ulcerative Colitis

Ulcerative Colitis Chronic
Guangzhou Institute of Respiratory Disease
Boehringer Ingelheim

Recruiting

Effect of Tiotropium Bromide Combined With Odaterol on Small Airway Remodeling in Patients With Mild to Moderate Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

China
Lipidor AB

Recruiting

A Phase III Study in Subjects With Mild to Moderate Psoriasis. (AKVANO-AKP02)

Mild to Moderate Psoriasis

India
Inmunotek S.L.

Recruiting

Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses.

Rhinitis, Allergic | Rhinoconjunctivitis | Asthma, Allergic

Spain
Inmunotek S.L.

Recruiting

Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen

Rhinitis, Allergic | Rhinoconjunctivitis | Asthma, Allergic

Spain
Societa Italiana di Pneumologia
Società Italiana di Allergologia, Asma e Immunologia Clinica

Recruiting

MANI Real-life Perspective Observatory (MANI)

Asthma | Moderate Asthma | Mild Asthma

Italy
Jordi Gol i Gurina Foundation
Institut Català de la Salut

Recruiting

Efficacy of Montelukast in Mild-moderate Respiratory Symptoms in Patients With Long-COVID-19: (E-SPERANZA)

Covid19 | SARS (Disease)

Spain
Inmunotek S.L.
BioClever 2005 S.L.

Recruiting

Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites (MM09-SIT-023)

Rhinitis, Allergic | Rhinoconjunctivitis | Asthma, Allergic

Spain
Bausch Health Americas, Inc.

Recruiting

Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis

Ulcerative Colitis

United States
Indiana University

Recruiting

5HTP Regulation Of Asthma In Children

Mild or Moderate Asthma With Allergic Sensitization

United States
Organon and Co

Completed

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Inhaled Montelukast (MK-0476) in Participants With Mild or Moderate Asthma (MK-0476-380 AM3)(COMPLETED)

Asthma
IntelGenx Corp.

Completed

Safety, and Efficacy of a New Buccal Film of Montelukast in Patients With Mild to Moderate Alzheimer's Disease (BUENA)

Alzheimer Disease

Canada
Imperial College London

Withdrawn

Endotoxin and Inflammatory Markers in Healthy Non-Smokers and Current Smokers Including Patients With Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease

United Kingdom
Principia Biopharma, a Sanofi Company

Completed

Phase 2a Study of the Safety, Tolerability, and Pharmacokinetics of Topically Administered PRN473 (SAR444727) in Patients With Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

United States, Canada
CSL Behring

Completed

A Clinical Study to Test the Safety, Exposure, and Pharmacodynamic Markers of CSL311 in Patients With Mild-to-moderate Asthma and in Healthy Volunteers

Asthma

United Kingdom, Germany
AstraZeneca
Amgen

Completed

Study to Evaluate the Pharmacokinetics of Tezepelumab in Children With Asthma (TRAILHEAD)

Asthma

United Kingdom, South Africa, Hungary
Inmunotek S.L.
BioClever 2005 S.L.; NTS hub S.L

Terminated

Efficacy and Safety Evaluation for the Treatment of Asthma and Allergic Rhinitis/Rhinoconjunctivitis

Perennial Allergic Rhinitis | Allergic Rhinoconjunctivitis | House Dust Mite Allergy | Pollen Allergy

Spain
Shanghai University of Traditional Chinese Medicine

Enrolling by invitation

A Clinical Study on the Prevention of Mild to Moderate Intermittent Asthma With Chinese Medicine Weiyang Yuping Fang

Bronchial Asthma

China
Bellerophon

No longer available

Pulsed Inhaled Nitric Oxide for the Treatment of Patients With Mild or Moderate COVID-19

COVID-19 | Coronavirus Infection | Pneumonia, Viral
Assistance Publique - Hôpitaux de Paris

Completed

Ulna Length in Black Children (ULNOIR)

Ulna Length in Otherwise Healthy Children (With the Exception of Mild to Moderate Asthma)

France
Massachusetts General Hospital
University of Alabama at Birmingham

Active, not recruiting

Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19 (NoCovid)

Coronavirus Infections | Pneumonia, Viral | Acute Respiratory Distress Syndrome

United States
Evelo Biosciences, Inc.

Completed

Study in Healthy Participants and Participants With Moderate Atopic Dermatitis & Optionally, Moderate Psoriasis, and/or Mild Asthma

Psoriasis | Asthma | Atopic Dermatitis

United Kingdom
Organon and Co

Completed

A Study to Compare Effectiveness of Montelukast Sodium With Comparator in Mild to Moderate Persistent Asthmatics (0476-329)

Asthma | Allergic Rhinitis
MEDA Pharma GmbH & Co. KG

Completed

5-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 - 12 Months of Age With Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

United States, Germany
Organon and Co

Terminated

Efficacy and Tolerability of Maintenance Treatment With Asmanex Twisthaler Versus Placebo in Mild/Moderate Persistent Asthmatics (Study P04654)(TERMINATED)

Asthma
Pfizer

Completed

A Study to Evaluate Long-Term Maintenance Treatment With Once Daily Crisaborole Ointment 2% in Pediatric and Adult Participants With Mild-to-Moderate Atopic Dermatitis

Atopic Dermatitis

China, United States, Turkey, Australia, Canada, Israel
Intech Biopharm Ltd.
Peking University People's Hospital; Beijing Friendship Hospital; The Second... and other collaborators

Completed

Clinical Equivalence of Budesonide HFA MDI Versus Budesonide Turbuhaler in Mild to Moderate Chinese Asthma Patients

Asthma

China
AZTherapies, Inc.

Terminated

A Safety and Biomarker Study of ALZT-OP1a in Subjects With Mild-Moderate ALS Disease

Amyotrophic Lateral Sclerosis

United States
Pfizer

Completed

Dose Ranging Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06700841 Topical Cream in Participants With Mild or Moderate Atopic Dermatitis

Atopic Dermatitis

Germany, United States, Canada, Denmark, Hungary, Australia, Latvia, Poland, Bulgaria, Japan
GlaxoSmithKline

Completed

First Time in Human (FTIH) Study to Evaluate Safety, Tolerability, Immunogenicity, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK3511294 Administered Subcutaneously (SC) in Subjects With Mild to Moderate Asthma

Asthma

United Kingdom, Germany
Sanotize Research and Development corp.
The Emmes Company, LLC; Keyrus Life Science

Completed

Nitric Oxide Releasing Solutions to Prevent and Treat Mild/Moderate COVID-19 Infection (NOCOVID)

Corona Virus Infection

Canada
Novartis Pharmaceuticals

Terminated

Efficacy, Safety and Pharmacokinetics of QAV680 Versus Placebo in Patients With Asthma

Asthma

Germany, Russian Federation, United States
Novartis

Completed

Tolerability of Indacaterol Salts (Maleate, Xinafoate and Acetate) in Comparison to Placebo in Patients With Mild to Moderate Persistent Asthma

Asthma

Canada
General Innovations and Goods, Inc.
National Institute of Allergy and Infectious Diseases (NIAID); University of... and other collaborators

Completed

Investigate the Effect of the CREON2000A on Asthma Control in Children With Mild to Moderate Persistent Asthma (CREON2000A)

Asthma

United States
Palobiofarma SL
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau; Hospital...

Completed

A Study to Assess the Efficacy of a 5-day, 10- mg PBF-680 Oral Administration on Late Asthmatic Responses (LAR) in Mild to Moderate Asthmatic Patients.

Asthma

Spain
Pfizer

Completed

Safety, Tolerability And Efficacy Study Of Topical PF-06763809 In Subjects With Mild To Moderate Chronic Plaque Psoriasis

Psoriasis

Germany
Ferring Pharmaceuticals

Completed

To Evaluate the Efficacy and Safety of FE 999315 in Japanese Subjects With Mild to Moderate Active Ulcerative Colitis

Colitis, Ulcerative

Japan
Actavis Inc.

Completed

Study of Equivalence of Generic Pimecrolimus Cream 1% and Elidel® 1% in Subjects With Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

United States
Xijing Hospital
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Withdrawn

Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID19 Infection (NoCovid)

Coronavirus Infections | Pneumonia, Viral | Dyspnea
Pfizer

Completed

A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

United States, Australia, Canada
Novartis Pharmaceuticals

Completed

A Randomized, Multicenter, Open-label, Parallel-group, 12-week Study to Assess the Efficacy and Safety of Switching From Tiotropium to QVA149 (Indacaterol Maleate/Glycopyrronium Bromide) in Symptomatic Mild to Moderate COPD Patients

COPD

Korea, Republic of
Dance Biopharm Inc.
WCCT Global

Terminated

PK and PD Profile of Dance 501 in Healthy, Non-diabetic Subjects With Mild to Moderate Asthma or COPD

Safety and Tolerability

United States
Bausch Health Americas, Inc.

Completed

Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis

Proctitis | Proctosigmoiditis

United States

3

Subscribe